home / stock / mreo / mreo news

MREO News and Press, Mereo BioPharma Group From 07/15/19

Stock Information
Company Name: Mereo BioPharma Group
Stock Symbol: MREO
Market: NASDAQ
Website: mereobiopharma.com
Menu
MREO MREO Quote MREO Short MREO News MREO Articles MREO Message Board
Get MREO Alerts

News, Short Squeeze, Breakout and More Instantly...
MREO - Mereo BioPharma Announces Successful Type B Meeting with U.S. FDA and Outlines Accelerated Approval Pathway for Navicixizumab in Advanced Ovarian Cancer

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN LONDON and REDWOOD CITY, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma...
MREO - Microcaps mostly among midday movers

Gainers:  VivoPower International (NASDAQ: VVPR ) +108% . Minerva Neurosciences (NASDAQ: NERV ) +43% . PCM (NASDAQ: PCMI ) +42% . Krystal Biotech (NASDAQ: KRYS ) +30% . NRC Group Holdings (NYSEMKT: NRCG ) +26% . India Globalization Capital (NYSEMKT: IGC ) +21% . Rekor Systems (R...

MREO - Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Update on Etigilimab (TIGIT) Partnership

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN LONDON and REDWOOD CITY, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma ...

MREO - Mereo Bio's setrusumab shows encouraging action in mid-stage bone disorder study

Mereo BioPharma Group plc (NASDAQ: MREO ) announces positive preliminary data from a Phase 2b dose-ranging study, ASTEROID , evaluating BPS-804 (setrusumab) in patients with Type I, II or IV osteogenesis imperfect a, an inherited disorder also called "brittle bone disease" due to fr...
MREO - Mereo BioPharma Group plc Announces Positive Early 6 Month Data from the Open Label Arm of the Phase 2b Clinical Study in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with the Anti-Sclerostin Antibody, BPS-804 (setrusumab)

Clear and encouraging percentage changes over baseline in trabecular volumetric bone mineral density measured at the radius at an early readout Expect topline 12 month data from the blinded arms of study to be available in fourth quarter 2019 A call for analysts and investor...

MREO - Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Intention to Purchase Shares by Trustee of Employee Benefit Trust

LONDON, May 03, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH, NASDAQ:MREO), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, today announces that the Trustee of the Mereo BioPharma Group plc Employee Benefit Trust (the “Trust”), L...

MREO - Mereo BioPharma Group Plc ("Mereo" or the "Company" or the "Group") Preliminary Results for the Year Ended December 31, 2018 -- Strong Operational Progress

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN. LONDON, April 29, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH) (N...
MREO - Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019

Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") LONDON, April 26, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH) (NASDAQ: MREO), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, today announced that it will release prelim...

MREO - Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Admission to trading on AIM of New Shares and initiation of trading on Nasdaq of American Depositary Shares

LONDON, April 24, 2019 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH) (NASDAQ: MREO), a clinical stage, UK-based, biopharmaceutical company focused on rare diseases, today announces that, in connection with the completed merger with OncoMed Pharmaceuticals, Inc. (“OncoMed&#...

MREO - U.S. IPO Weekly Recap: Lyft And Pinterest Edge Closer To IPO

Unicorns are finally inbound. News broke that Lyft (LYFT) is prepping an IPO filing this coming week, which would put it on track for a late-March listing. Another "decacorn," Pinterest (PINIT), reportedly filed confidentially for an IPO expected around late June. Just one company submitted ...
Previous 10 Next 10